Digitization and health: Which developments worldwide set standards for the future of medical care for people? A meta topic is the handling of data. Buzzwords such as big data and artificial intelligence are the focus of the discussion. Medical and pharmaceutical research are progressing at a breathtaking pace to generate ever new data-based achievements and business models. Who are the founders? Where are the limits? Is there an ethical corrective?
The Health meets Future Summit takes account of the increasing digitalization of the health sector and is dedicated to innovations in medicine, the pharmaceutical industry, the life sciences and biotechnology. The summit highlights current findings from research and development as well as new digital business models and their growth potential, without neglecting the patient perspective.
International thought leaders and decision-makers discuss The following key questions about digital transformation:
- Resources & regulations – what positive role can legislation play in the health business in times of artificial intelligence and big data?
- Improve healthcare decision-making with data science and advanced AI – a mega-market with a future?
- Digitization and health – global trends, Germany’s role in the global future market
- E-health and big data in healthcare – what do patients want, especially silver surfers?
- Who’s better – who’s best? – Innovative business models from the health business face the auditorium
The conference language is English.
The event hashtag is #HealthSummit.
The final conference program is expected to be available as a PDF download in mid-May.
If you are interested in helping shape the Health meets Future Summit, please contact the contact person below.
Speakers from last years (extract)
Prof. Dr. Michael Forsting
Director, Institute of Diagnostic and Interventional Radiology and Neuroradiology, Essen University Hospital
Professor Dr. med. Michael Forsting is Medical Chairman of Central IT at the University Hospital Essen and Chairman of Diagnostic and Interventional Radiology and Neuroradiology at the University Hospital Essen. His scientific work focuses on experimental and clinical research on stroke, MR imaging of cerebral disorder and brain tumors and endovascular therapy of intracranial vascular malformations. He is Vice Dean (Research) of the Medical Faculty of the University Hospital Essen and Member of the Leopoldina (National Academy of Sciences). He has published more than 500 original papers.
Prof. Dr. Robin Haring
Professor of Public Health, European University of Applied Sciences (EUFH), Faculty of Applied Public Health
Prof Haring is an expert in cardiovascular epidemiology and public health. He studied demography at the University of Rostock (Diploma, 2006), completed his PhD at the University of Greifswald (2010) and spend his Post-Doc at Boston University in the Framingham Heart Study (2011). After his habilitation on the role of testosterone as men’s health biomarker (2013) he was appointed 2014 as full professor at the European University of Applied Sciences (EUFH) and 2016 as adjunct professor at Monash University, School of Public Health and Preventive Medicine. Prof Haring actively publishes on the challenges and impact of digital healthcare on public health.
Mitglied der Hauptgeschäftsführung, BDI e.V.
Iris Plöger wurde 1971 in Hamburg geboren. Sie studierte Rechtswissenschaften in Kiel und dem Vereinigten Königreich. Im Anschluss war sie als Wissenschaftliche Mitarbeiterin am Institut für Wirtschafts- und Steuerrecht der Christian-Albrechts-Universität zu Kiel tätig. Nach dem Zweiten Juristischen Staatsexamen arbeitete Iris Plöger ab 2000 als Rechtsanwältin mit Schwerpunkt Wettbewerbs- und IT-Recht in der internationalen Wirtschaftskanzlei Freshfields Bruckhaus Deringer.
2004 wechselte sie in die Rechtsabteilung des BDI und übernahm 2015 die Leitung der Abteilung Digitalisierung und industrielle Wertschöpfungsstrukturen im BDI. Seit 2016 leitete sie dann im BDI die Abteilung Digitalisierung, Innovation und Gesundheitswirtschaft.
Seit April 2017 ist Iris Plöger Mitglied der Hauptgeschäftsführung des BDI.
Managing Director, HMG Systems Engineering GmbH
Herna Muñoz-Galeano has over 25 years of experience in specification, development, integration and management of complex engineering systems. Since 1998, Herna has been an independent entrepreneur with a special interest in transforming science into innovative products and systems. She also has knowledge of standardization at ITU, ETSI and IEEE. She has perfected the methods which optimize the development process, including integration and testing processes, for breakthrough complex technical systems. By applying the “functional anatomy” method, all projects have been completed within the given time frame and budget Herna’s way of working is analytic and systematic and has made her who she is today. Respect, openness and trust are very important to her. Her employees and customers value her fast and logical judgment as well as her reliability and social competence. She is clientservice oriented and is always open for new challenges. Due to her international background, Herna Muñoz-Galeano speaks English and German fluently and Spanish is her native language. She has implemented projects in Germany, Sweden, Spain, the Netherlands, the United Kingdom and Brazil. Herna Muñoz-Galeano holds a master’s degree in Electronics Engineering from the Universidad Distrital Francisco José de Caldas in Bogotá, Colombia, and a master’s degree in Computer Science from the Friedrich-Alexander-University in Erlangen-Nuernberg, Germany. On 29th April 2016, Herna Muñoz-Galeano was awarded the Career Award “Engineer PowerWoman 2016” by the Deutsche Messe AG at the Hannover Messe. Since 1998, Herna has been an independent entrepreneur and managing director of HMG Systems Engineering GmbH, which emerged in 2014 from the merger of two other companies established by Herna. HMG Systems Engineering GmbH was awarded in 2016 as one of the Top 100 (top100.de) most innovative SMEs in Germany.
Managing Director, Health Angels GmbH
Karin studied communications science and graduated from the German School of Journalism in Munich, Germany. In 1997 she founded the strategic publication planning agency pluspool, which she brought to TBWA in 2010. After three and a half years as Managing Director at TBWA Germany, she then transferred to greyhealth group, where she spent four years as CEO. Since 2018, she has been the managing director of health angels, the healthcare agency within the Hirschen Group. Karin brings with her a long list of international clients such as Pfizer, Roche, Bayer, Olympus, GE Healthcare, Santen, Ipsen, Merck, Fresenius Kabi, Janssen and Colgate, to name just a few. Her fields of expertise range from andrology and virology to blockbuster brands and ultra rare diseases. For her, healthcare communication has to be unusual, challenging, fascinating, unmatched, grandiose and, above all, logical. Because in the end, it has to help people while changing the way they think.
Dr. Stefan Rüping
Head of Big Data Analytics, Fraunhofer Institute for Intelligent Analysis and Information Systems IAIS
Professor Dr. Yoshiyuki Sankai
CEO and President, CYBERDYNE, INC., Professor Dr., University of Tsukuba, Program Manager, ImPACT, promoted by Cabinet Office, Government of Japan
Yoshiyuki Sankai is a professor and Executive Research Director at the Center for Cybernics Research, University of Tsukuba; the President and CEO of CYBERDYNE, INC.; and a Program Manager of the Impulsing Paradigm Change through Disruptive Technologies (“ImPACT”) program, which was initiated by the Council for Science, Technology and Innovation (“CSTI”) of the Cabinet Office in Japan. He is a fellow of the Robotics Society of Japan (“RSJ”) and the Society of Instrument and Control Engineers (“SICE”) . He also served as Chairman and an Executive Board Member of Advanced Robotics. He is a member of Global Future Council on Human Enhancement of the World Economic Forum.
He has received numerous awards, including: The 2005 World Technology Award (World Technology Network), The 2012 Capek Award (INNOROBO), The 2014 Technology Pioneer (World Economic Forum), Gold Prize of 2014 Edison Awards, DealWatch Awards 2013 IPO of the Year (Thomson Reuters), DealWatch Awards 2014 Innovative Equity Deal of the Year (Thomson Reuters), The 2016 DIA Japan Outstanding Contribution to Health Award, the 7th Robot Award (Ministry of Health, Labour and Welfare award), and the Prime Minister’s Award (the third Nippon Venture Awards) in 2017.